SCHEMBL6071379

SCHEMBL6071379

Fc1ccc(Nc2ccnc3c(Cl)cccc23)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK6 Q13882 1/20 0.59
CD38 P28907 1/20 0.50
GRM4 Q14833 3/20 0.49
EGFR P00533 2/20 0.49
FADS1 O60427 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
AURKA O14965 1/20 0.46
RPS6KB1 P23443 1/20 0.46
HTT P42858 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ACP1 P24666 1/20 0.45
TGFBR1 P36897 1/20 0.44
NR4A2 P43354 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
KDR P35968 1/20 0.43
TDO2 P48775 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071256 0.88 PTK6 (0.56) PTK6CD38GRM4EGFRFADS1
SCHEMBL4741727 0.85 FADS1 (0.68) PTK6GRM4EGFRFADS1SMN1; SMN2
SCHEMBL6071699 0.82 FADS1 (0.68) PTK6CD38EGFRFADS1HTT
SCHEMBL4740984 0.81 PTK6 (0.53) PTK6CD38GRM4EGFRPTGS1
SCHEMBL4740968 0.76 CD38 (0.65) PTK6CD38EGFRFADS1TGFBR1
SCHEMBL4961504 0.75 CD38 (0.61) PTK6CD38EGFRFADS1TGFBR1
SCHEMBL1617583 0.75 KDR (0.48) PTK6EGFRSMN1; SMN2KDM4EALDH1A1
Hydrochloric Acid SCHEMBL10739446 0.75 SMN1; SMN2 (0.46) FADS1SMN1; SMN2KDM4EALDH1A1AURKA
SCHEMBL23117519 0.74 CD38 (0.62) PTK6CD38EGFRFADS1KDM4E
SCHEMBL4787800 0.73 CD38 (0.64) PTK6CD38EGFRFADS1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same WYETH (US) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same TNNI3K, CSNK1A1L, CDKL1 PTK6 180/4885CD38 941/4885GRM4 4270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.